Abstract
In recent years, there has been considerable interest in using adenoviruses as live vectors to develop recombinant vaccines. Previous studies have demonstrated the safety and effectiveness of HIV/SIV and influenza vaccine candidates based on human adenovirus type 4 (Ad4) replication-competent vectors in rhesus macaque and human model. To explore the possibility of human Ad4 vaccine strain used as a vector in developing porcine vaccines, the growth properties of replication-competent human Ad4 vaccine strain recombinant encoding EGFP in different porcine cell lines were investigated. All tested cell lines are permissive for Ad4 vaccine strain vector with varied replication efficiency. Thus, human Ad4 based vectors would be promising supplement to adenovirus vectors as a delivery vehicle for recombinant vaccines in swine industry.
Original language | English |
---|---|
Pages (from-to) | 83-85 |
Number of pages | 3 |
Journal | Research in Veterinary Science |
Volume | 104 |
DOIs | |
State | Published - Feb 1 2016 |
Externally published | Yes |
Keywords
- Adenovirus type 4
- Live vector
- Porcine cell lines
- Recombinant vaccine
- Replication